GEMALS: A promising therapy for amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that currently has no cure. At present, the only approved treatment for ALS is Riluzole, a glutamate release blocker that improves life expectancy by 3–6 months. ALS-Endotherapia (GEMALS) is a novel therapeutic approach to treat ALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Geffard, Michel, Mangas, Arturo, Bedat, Denis, Coveñas, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841048/
https://www.ncbi.nlm.nih.gov/pubmed/29545836
http://dx.doi.org/10.3892/etm.2018.5868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841048/
https://www.ncbi.nlm.nih.gov/pubmed/29545836
http://dx.doi.org/10.3892/etm.2018.5868

Ejemplares similares